RE:RE:RE:RE:RE:RE:Label
m80, if you invest in biotech/pharma on a regular basis, all that's been in the news from the recent immunotherapy/oncology drug developments/approvals is EARLY APPROVAL, ON AVERAGE ONE MONTH; additionally recent interviews with FDA bosses have confirmed those actions/intentions.......................................maybe I am correct about our decision......just one day late. At worst, I hope, maybe a delay or workable CRL. I hope and pray not; especially for dying bladder cancer patients..........GL all